Our research and development programs currently focus on potential treatments in Oncology, CNS,
and Rare diseases.
We strive to target fields that have high unmet medical needs to conduct research for new
innovative drugs, generics and incrementally-modified drugs(IMDs) to potentiate YJP's value among
global pharmaceutical trends.
- YJP Platform Technology
- Fixed-Dose Combination Multi layered FDC Multi layered coating FDC
- Controlled Release Hydrogel matrix system Multi layered tablet Floating Release
- Absorption Enhancement Hydrophilic polymer system Micro-emulsion Solid dispersion Nano-particulation
- New Salt Formulation Salt Solvate Complex
- Dosage Form Change Solution Chewable tablet Orally disintegrating tablet(ODT)